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Abstract
Background: Patients hospitalized on acute psychogeriatric wards are a heterogeneous population. Cluster
analysis is a useful statistical method for partitioning a sample of patients into well separated groups of patients
who present common characteristics. Several patient profile studies exist, but they are not adapted to acutely
hospitalized psychogeriatric patients with cognitive impairment. The present study aims to partition patients
hospitalized due to behavioral and psychological symptoms of dementia into profiles based on a global
evaluation of mental health using cluster analysis.
Methods: Using nine of the 13 items from the Health of the Nation Outcome Scales for elderly people (HoNOS65+),
data were collected from a sample of 542 inpatients with dementia who were hospitalized between 2011 and 2014 in
acute psychogeriatric wards of a Swiss university hospital. An optimal clustering solution was generated to represent
various profiles, by using a mixed approach combining hierarchical and non-hierarchical (k-means) cluster analyses
associated with a split-sample cross-validation. The quality of the clustering solution was evaluated based on a
cross-validation, on a k-means method with 100 random initial seeds, on validation indexes, and on clinical
interpretation.
Results: The final solution consisted of four clinically distinct and homogeneous profiles labeled (1) BPSD-affective,
(2) BPSD-functional, (3) BPSD-somatic and (4) BPSD-psychotic according to their predominant clinical features. The
four profiles differed in cognitive status, length of hospital stay, and legal admission status.
Conclusion: In the present study, clustering methods allowed us to identify four profiles with distinctive characteristics.
This clustering solution may be developed into a classification system that may allow clinicians to differentiate patient
needs in order to promptly identify tailored interventions and promote better allocation of available resources.
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Background
Around 110,000 people currently suffer from dementia in
Switzerland [1]. By 2050, demographic trends suggest that
its prevalence will triple [2]. The overall annual direct and
indirect costs of dementia in Switzerland amount to CHF
6.9 billion [1]. Thus, dementia already has a significant
impact on healthcare systems; its complications include
individual suffering, family burdens, increasing needs for
nursing and interprofessional care, and longer hospital
stays [3–5]. Behavioral and psychological symptoms of
dementia (BPSD) are universal and affect nearly all pa-
tients over the course of dementia [6–8]. They have nega-
tive consequences such as high level of caregiver distress
[9, 10], poor quality of life not only for patients but also
for their formal and informal caregivers [11–13], and a
significant increase in costs [14, 15]. Moreover, BPSD con-
stitute a major cause of hospital admissions [16].
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It is commonly considered that psychogeriatric inpa-
tients with dementia constitute a heterogeneous popu-
lation and some research has already focused on BPSD
profiles in dementia [17–20]. However, to date, the dif-
ferent patient profile studies combining somatic and
psychiatric problems with socio-relational information,
clinical evolution and care management are poorly de-
scribed. Consequently, better knowledge regarding pa-
tients’ profiles in this type of setting is needed to better
inform future health policy decisions regarding demen-
tia care [21].
To better target the needs of these patients and, thus,
more effectively adjust the interventions and resources
required, a multidimensional assessment of health is
essential; it should include the dimensions of psycho-
pathology, social functioning, cognition, pain/discomfort
and other physical features as well as satisfaction [22].
Although using the overall score from a multidimen-
sional assessment tool can give an indication as to the
severity of a clinical situation, it does not provide a true
representation of the various components involved. In-
deed, a similar score on a given scale can be the result
of different combinations of simultaneous health condi-
tions. Cluster analysis is a useful way of identifying the
different profiles present in a heterogeneous population.
Identifying groups of people who share similar charac-
teristics will help to better understand those characteris-
tics [23, 24]. Attributing a label to each group allows
professionals to use a common language and facilitates
discussion and information sharing. Also, in the health-
care sector, classifications developed by cluster analyses
gather individuals who require the same resources and,
until now, they were mainly created in order to facilitate
the efficient attribution of limited resources [25, 26].
Knowledge about people’s affiliation to a specific profile
offers refined information that helps to determine the
most efficient interventions required in various situa-
tions and also enables the development of a classification
system. For example, the Iso-SMAF profiles, developed
in Canada, is a disability-based classification system for
the management of long-term care needs in an inte-
grated service delivery system [27].
So far, several studies have developed classification
systems for psychiatry based on the prediction of a
dependant variable using statistical methods such as
regression tree analysis, namely the Psychiatric Patient
Classification System [28], the Patient Casemix Classifica-
tion [29], the Australian National Subacute and Non-
Acute Patient classification (AN-SNAP, Versions I and II)
[30, 31], the Long-stay Psychiatric Patient Classification
system [32], the System for Classification of In-Patient
Psychiatry (SCIPP) [33], the Mental Health Care Clusters
[34] and the mental health Classification And Outcomes
Study (NZ CAOS) [35, 36]. The characteristics of these
seven classification systems have been summarized in
Additional file 1. Considering that the development of a
new classification system is an arduous task, the use of an
existing and operational foreign system could have been
judicious. However, the above classifications were devel-
oped to correspond to the specific healthcare system in
which they were developed. When an attempt was made
to transfer the American Resource Utilization Groups
specially designed to estimate the costs of long term insti-
tutions to England, it was unsuccessful [37]. Indeed,
American, but not British long-term care, is provided in
rehabilitation settings, illustrating the importance of the
fit between healthcare systems to consider the transfer of
a foreign classification system. In the context of this study,
the Canton of Vaud has a specific healthcare organization
and has developed acute psychogeriatric wards specifically
dedicated to the management of patients with BPSD; these
wards are located in three different regions in an effort to
offer proximity services to patients and their families. Each
of the classifications reviewed was developed for specific
psychiatric organizations and did not accurately match the
specificities of psychogeriatric inpatients in the Swiss
French context. Furthermore, several points in the classifi-
cation development have to be taken into consideration
concerning the statistical methods, the variables to be
included in the analysis and the sample.
Firstly, all the classifications, except the Mental Health
Care Clusters [34] and the Psychiatric Patient Classification
System [28], use costs as a dependent variable in their de-
velopment; however, from a clinical point of view, this
should not be the case [38]. Indeed, when groups are de-
fined by the amount of resources they require, classification
becomes more difficult especially when a new intervention
which requires a change in resources is used on a specific
group. By defining groups based on clinical features and
clinical relevance, the introduction of new procedures will
be guided by the characteristics of the group.
Secondly, using diagnosis as a classification variable - as
in the Psychiatric Patient Classification System [28], the Pa-
tient Casemix Classification [29], and the AN-SNAP [30] -
is not adequate for aged psychiatric inpatients. Indeed, it is
difficult to classify these patients when the mental health
diagnosis is not the main reason for hospitalization. It is
common for psychogeriatric patients to be hospitalized
when home care, nursing home care or care in a general
hospital become too difficult. This can be the case with a
patient with behavioral disorders, a caregiver suffering
from exhaustion, or the failure/refusal of care.
Thirdly, none of the classifications reviewed was deve-
loped to meet the specific needs of older people with
cognitive impairment hospitalized in geriatric psychiatry
units. All of them were developed on the basis of sam-
ples composed of adults and aged patients and the NZ
CAOS [35, 36] was developed for all ages. The selection
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of the sample for the development of classification is es-
sential and must be carefully planned [23, 24]. If individ-
uals of different ages constitute the sample, dissimilarities
across the different age groups will cancel out differences
among individuals of the same age. Thus, psychogeriatric
inpatients with dementia should be the only subjects to be
included in the classification developement procedure.
For all the aforementioned reasons, none of the exist-
ing and operational foreign classification systems could
be applied to our specific population of aged patients
with cognitive impairment hospitalized in acute geriatric
psychiatry units. Moreover, there is a need to develop a
partition of these patients using clustering methods
rather than classification methods based on the predic-
tion of costs. Of all the classification systems reviewed,
only the Mental Health Care Clusters [34] used a cluster
analysis to obtain profiles of patients. However, these
profiles were developed on the basis of samples of
patients with different psychiatric issues, such as depres-
sion or schizophrenia. As with age, dissimilarities across
these groups will cancel out differences among individ-
uals with dementia.
Implemented in daily practice in Switzerland, the
Health of the Nation Outcome Scale for elderly people
(HoNOS65+) [39, 40] assesses the global mental health,
independently from the diagnosis. It allows the measure-
ment and the follow-up of physical, personal and social
issues associated to psychiatric disorders. Thus, the
HoNOS65+ offers the opportunity to identify patient
profiles based on multiple characteristics.
Consequently, the aim of our study was the develop-
ment of profiles using cluster analysis of psychogeriatric
patients hospitalized with dementia in Switzerland. The
objectives were i) to find the optimal partition of patient
profiles based on HoNOS65+ items as provided by clus-
ter analysis; ii) to evaluate the validity, reliability, and
clinical interpretation and meaningfulness of the final
clustering solution; and iii) to describe the characteristics
of each profile.
Methods
Design, sampling, settings, and data collection
procedures
This study involved elderly patients with dementia who
were hospitalized in one of three psychogeriatrics wards
in French-speaking Switzerland between January 1, 2011,
and June 30, 2014. Only the first hospitalization during
the set period was taken into account.
Routinely collected data were used. These were under
the responsibility of the head of the geriatric psychiatric
service (AvG). Data were retrieved by a data manager
who gave access to the data set after approval by the
cantonal Human Research Ethics Committee (protocol
no 231/14).
Subsequently, the main investigator (COB) met the
canton’s centralized psychiatric hospital data manager
to select subjects with a clinical diagnosis of dementia
(according to the International Classification of Dis-
eases, Tenth Revision) at admission to hospital. Clinical
data was collected from the patients’ medical charts and
the database containing all hospital stays in the cantonal
psychogeriatrics wards during the study period; only initial
stays were considered. Other medical data were retrieved
to complete the clinical data that were not available in the
computerized database. Reasons for hospital admission
and the Mini-Mental State Examination (MMSE) [41]
score at entry were collected in order to evaluate cognitive
level. If the MMSE score was missing, the reason why that
data was missing was recorded. We also noted the pres-
ence of comorbidities in order to calculate a comorbidity
score using the Cumulative Illness Rating Scale for Geriat-
rics (CIRS-G) [42, 43]. Finally, the length of hospital stay in
acute care was registered using the three cantonal medical
insurance copayment categories found on patient charts:
acute care, rehabilitation, and waitlisted for placement.
Of the 1104 patients meeting the inclusion criteria,
562 (51 %) had an incomplete HoNOS65+ assessment;
this was due to a lack of time needed to complete the as-
sessments at entry, making those assessments unusable
for assessing the development of different profiles. For
clinical purposes, HoNOS65+ assessments were made by
at least two members of medical staff. Data about the
remaining 542 (49 %) patients were used in our analysis.
The two groups (with or without complete HoNOS65+
assessment) did not differ in age (81.34 vs. 81.49 years
old; diff = −0.148 [95 % CI = −1.150–0.854]), CIRS-G
score (19.43 vs. 18.70; diff = 0.727 [95 % CI = −0.069–
1.522]), or MMSE score (17.42 vs. 16.64; diff = 0.778
[95 % CI = −0.304–1.860]).
With regards to this sample size, Dolnicar et al. [44]
conducted simulations to estimate adequate sample sizes
for market segmentation studies. According to the num-
ber of clusters, their separation index (amount of space
between two clusters), and the number of noisy vari-
ables, the optimal sample size should range between 30d
to 40d, where d is the number of variables included in
the cluster analysis. A more conservative sample size re-
quirement would be 70d. In the present study, nine vari-
ables and a sample size of 542 correspond to a sample
size of 60d which was thus considered to be adequate.
Development, validation, and selection of the best profile
solution
Our cluster analysis was based on the French version of
the HoNOS65+ [39, 45]. This scale is a diagnostic-
independent assessment of mental health and social func-
tioning. The 13 items were: (1) “behavioral disturbance”;
(2) “non-accidental self-injury”; (3) “problem drinking or
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drug use”; (4) “cognitive problems”; (5) “problems related
to physical illness or disability”; (6) “problems associated
with hallucinations and/or delusions or false beliefs”; (7)
“problems associated with depressive symptoms”; (8)
“other mental and behavioral problems” (including pho-
bias, anxiety and panic, obsessive-compulsive symptoms,
mental strain and tension, dissociative and conversion
problems, somatoform problems, eating disorder, sleep
problems, sexual problems and other); (9) “problems with
social or supportive relationships”; (10) “problems with
activities of daily living”; (11) “overall problems with
living conditions”; (12) “problems with work and leisure
activities—quality of daytime environment”; and (13)
“drug management”.
For each item, the observer chose the highest score
applicable to the patient during the 2 weeks prior to the
assessment. Each item was rated on a 5-point Likert
scale as follows: 0 (no problem); 1 (a moderate problem
requiring no action); 2 (a moderate but existing problem
requiring monitoring and intervention for hospitalized pa-
tients), 3 (a moderately severe problem); 4 (a very severe
problem) [46].
The scale showed good inter-rater reliability [47, 48],
and associations between the individual HoNOS65+ items
and other relevant established scales were generally ad-
equate. For example: the HoNOS65+ behavioral disturb-
ance item (item 1) was found to correlate with the Brief
Agitation Rating Scale [39, 47]; the HoNOS65+ activity of
daily living (ADL) item (item 10) was found to correlate
with ADL, Instrumental ADL, and the Barthel rating
scales for ADL [39, 40, 48]; the HoNOS65+ cognitive
problems item (item 4) was found to correlate with
MMSE scores [39, 47, 48]; the HoNOS65+ depression
item (item 7) was found to correlate with the Geriatric
Depression Scale [39, 47, 48]; and the HoNOS65+ physical
illness item (item 5) was found to correlate with the
CIRS-G [48].
To select relevant variables to be included in the clus-
ter analysis, we examined each variable’s frequency, level
of correlation, and whether it was properly representa-
tive of patients’ conditions. Based on this information,
we used nine items of the HONOS65+ scale (items 1, 4–
10, and 13). Item 2, “non-accidental self-injury”, and item 3,
“problem drinking or drug use”, were not included because
these problems were scarcely represented in aged patients
with more advanced dementia. Item 11, “overall problems
with living conditions”, and item 12, “problems with work
and leisure activities—quality of daytime environment”,
were not considered as they were more representative of
patients living in a nursing home or at home alone.
In cluster analysis, hierarchical and non-hierarchical
methods exist, each having advantages and disadvantages.
The combination of both allows for the advantages of one
approach to compensate for the weaknesses of the other.
We applied the clustering process proposed by Hair [24]
using a mixed approach combining hierarchical and non-
hierarchical (k-means) cluster analysis. We also performed
a split-sample cross-validation as proposed by Punj and
Stewart [49] and calculated Kappa coefficients to test the
reliability of the classification. This split-sample cross-
validation procedure was performed simultaneously with
the clustering process (Fig. 1).
For the cross-validation, the 542 subjects were ran-
domly divided into two data sub-samples (S1 for the
clustering development and S2 for the cross-validation,
60 and 40 % of patients each, respectively). On S1, we
first applied Ward’s clustering hierarchical method using
the Euclidian distance. We calculated solutions for three
to seven clusters. Given the non-uniqueness of the solu-
tion in the agglomerative hierarchical cluster if ties exist
[50], we performed the cluster analysis on four data per-
mutations. Additionally, we compared the four solutions
two-by-two by calculating percent agreements. If at least
70 % of observations fell in the same clusters at least in
three of the four solutions, then the centroids of these
observations were calculated in order to determine the
initial cluster centroids. Second, the K-means method - a
non-hierarchical procedure that clusters all observations
using the initial clusters centroids solution from the hie-
rarchical procedure - was used to provide more accurate
cluster membership (solution S1).
Using sub-sample S2, clustering solutions were devel-
oped in two different ways to proceed to a cross-validation.
First, the solution called S2_a was created by the classifica-
tion of each observation of sub-sample S2 according to the
nearest distance of the final centroids obtained from
the k-means solution of sub-sample S1. Second, the
S2_b solution was obtained independently repeating the
mix-method approach (hierarchical and k-means) as
described above for S1. These two alternative solutions
(S2_a and S2_b) were then compared by calculating a
Kappa agreement coefficient. The minimum threshold
of 0.61 was used as the criterion for retaining a solution
[51]. Third, the clustering process was repeated on the
whole sample in order to obtain the final solution on
which was computed the Calinski-Harabasz index with
the aim to determine the optimal number of clusters
(see below). This technique was applied on solutions
from three to seven clusters (Fig. 1).
In addition to the Kappa coefficient used to evaluate
reproducibility, we applied the Calinski-Harabasz index
[52] to assess the ideal number of clusters. This statis-
tical index is a weighted ratio of between- to within-
cluster variance. If clusters are well-separated and
compact, the between-cluster variance is large whereas
the within-cluster variance is small. Thus, large values
of the Calinski-Harabasz index are indicators of a
better data partition. Compared to other criteria, this
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index is the most efficient [53] and is recommended by
several authors [23, 24].
To assess the robustness of the final selected solution,
we used the K-means method with 100 random initial
seeds with the same number of clusters [54] as an alter-
native method. Among the 100 solutions, the one which
minimized the sum of distances from observations to
their centroid was retained. Memberships between the
two solutions were examined using a Kappa coefficient.
In order to validate the final solution, differences in
variables (between profiles) that were not used in the
cluster analysis itself, but that are supposed to vary
across profiles, were tested. For the present study, we
selected the following variables: cognitive level measured
by the MMSE [41], comorbidities evaluated using the
CIRS-G [42, 43], length of stay in acute care, total length
of hospital stay, and legal admission status. The Krus-
kall–Wallis, ANOVA and χ2 tests were used to compare
the differences between clusters for continuous and
categorical variables, respectively. All analyses were per-
formed using in-house programming and the statistical
software IBM SPSS Statistics, version 23 [55]. No special
package was used.
Results
Description of the final profiles
Statistical properties of the solutions from three to seven
clusters are illustrated in Table 1. The 4-cluster and the 5-
cluster solutions showed the highest values of Calinski-
Harabasz index and Kappa coefficient (267.41/0.83 vs
275.5/0.64 respectively). Considering that the Calinski-
Harabasz index varied slightly between the two solutions
unlike the Kappa coefficient which decreased substantially
in the 5-cluster solution, the 4-cluster solution was finally
selected. Furthermore, the 5-cluster solution did not pro-
vide more clinical information than the 4-cluster solution,
and we easily observed in the data that the fifth profile in
the 5-cluster solution was mainly the result of the division
of one profile of the 4-cluster solution into two. These
two profiles present similar patterns but slightly different
levels of acuity.
Memberships between the two optimal 4-cluster solu-
tions obtained by i) the mixed clustering approach with
cross-validation, and by ii) the k-means method with
100 random initial seeds, were examined and showed a
Kappa coefficient of 0.74, illustrating the robustness
among methods for this solution.
As shown in Table 2 and illustrated in Fig. 2, each profile
contained a reasonable proportion of patients (14–42 %).
The nine items of the HoNOS65+ gave a maximum score
of 36. Table 3 illustrated repartition details of HoNOS65+
Ward method on 
4 random orders
K-means method
with Ward solution 
for initial centroids
Identification of 
centroids and 
group numbers
542 patients with complete HoNOS at admission
Solution S1
1) S1  sub-sample
(60%)
Forced solution
based on S1 
solution centroids
Solution S2_b
Kappa
2) S2  sub-sample
(40%)
Same procedure
as S1
Solution S2_a
3) Whole
Sample
Final solution
Same procedure
as S1
Measures of 
homogeneity, 
heterogeneity
Fig. 1 Illustration of the clustering procedure
Table 1 Statistical validation criteria of the solutions from three
to seven clusters
Calinski-Harabasz index Kappa coefficient
3-cluster solution 308.26 0.41
4-cluster solution 267.41 0.83
5-cluster solution 275.50 0.64
6-cluster solution 221.99 0.57
7-cluster solution 200.54 0.55
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item (8) “other mental and behavioral problems”. As
shown in this table, anxiety was by far the most frequent
problem reported by this item. Eating and sleeping disor-
ders were also present but less prevalent whereas phobia,
obsessive-compulsive symptoms, mental strain, dissociative
and sexual problems were scarce in our study sample.
Based on ANOVA tests, total mean scores of HoNOS65+
differed between profiles (F(3538) = 218.86, p < 0.000). Post
hoc comparisons using Tukey B revealed no differences
between profiles 1 and 2 with relatively low total mean
scores (respectively m= 14.70 and m= 15.22). Profiles 3
and 4 had high total mean scores (respectively m= 22.70
and m= 24.71) that were different from one another and
from the mean scores of profiles 1 and 2. Based on clinical
meaningfulness, we labeled the four profiles as BPSD-
affective, BPSD-functional, BPSD-somatic, and BPSD-psych-
otic, respectively. The BPSD-affective and BPSD-functional
profiles were different from the BPSD-somatic and BPSD-
psychotic profiles in several HoNOS65+ items. People
included in the BPSD-affective and BPSD-functional pro-
files showed fewer behavioral disorders, milder cognitive
impairment, and fewer somatic problems than those in the
BPSD-somatic and BPSD-psychotic profiles. The BPSD-
affective profile was associated with mental health
Table 2 Description of the four profiles
BPSD-affective BPSD-functional BPSD-somatic BPSD-psychotic
n 233 95 137 77
HoNOS-1 mean (95%CI) 1.61 (1.45–1.77) 1.38 (1.14–1.62) 2.64 (2.46–2.82) 2.65 (2.38–2.92)
HoNOS-4 mean (95%CI) 2.94 (2.81–3.06) 2.80 (2.63–2.97) 3.39 (3.29–3.50) 3.26 (3.03–3.49)
HoNOS-5 mean (95%CI) 1.74 (1.58–1.90) 1.62 (1.37–1.87) 3.18 (3.03–3.32) 2.12 (1.80–2.44)
HoNOS-6 mean (95%CI) 0.74 (0.59–0.89) 0.46 (0.29–0.64) 0.20 (0.11–0.28) 3.22 (3.05–3.39)
HoNOS-7 mean (95%CI) 1.59 (1.43–1.75) 1.15 (0.92–1.38) 1.56 (1.35–1.77) 2.10 (1.82–2.38)
HoNOS-8 mean (95%CI) 2.27 (2.11–2.43) 1.35 (1.08–1.61) 2.86 (2.67–3.05) 2.57b (2.29–2.86)
HoNOS-9 mean (95%CI) 1.42 (1.26–1.58) 1.01 (0.79–1.23) 2.74 (2.58–2.90) 2.94 (2.70–3.17)
HoNOS-10 mean (95%CI) 2.28 (2.14–2.42) 2.59 (2.42–2.76) 3.32 (3.21–3.43) 3.08 (2.83–3.33)
HoNOS- 13 mean (95%CI) 0.12 (0.07–0.16) 2.86 (2.73–2.99) 2.82 (2.67–2.97) 2.78 (2.52–3.04)
HoNOS- Total mean (95%CI) 14.70 (14.13–15.28) 15.21 (14.55–15.88) 22.70 (22.21–23.20) 24.71 (23.79–25.63)
HoNOS-1: Behavioral disturbance
HoNOS-4: Cognitive problems
HoNOS-5: Problems related to physical illness or disability
HoNOS-6: Problems associated with hallucinations and/or delusions or false beliefs
HoNOS-7: problems associated with depressive symptoms
HoNOS-8:Other mental and behavioral problems
HoNOS-9: Problems with social or supportive relationships
HoNOS-10: Problems with ADL
HoNOS-13: Drug management
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Fig. 2 Illustration of the four clustered profiles. Profiles’ mean score on HoNOS65+ variables
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problems, mostly depression and anxiety, but not with
psychotic symptoms. The BPSD-functional profile was
mainly associated with a loss of independence in ADL and
with the management of psychiatric drugs linked with diffi-
culties in social relationships. Patients in the BPSD-somatic
and the BPSD-psychotic profiles showed both a high level
of cognitive impairment and dependence in ADL, more
problems in social relationships and medication manage-
ment, and presented other psychiatric disorders. However,
people belonging to the BPSD-somatic profile had more
somatic comorbidities than those belonging to the BPSD-
psychotic profile, who experienced more psychotic
symptoms.
Table 4 summarizes reasons for admission across pro-
files, and Table 5 summarizes other variables not in-
cluded in the cluster analysis. The most frequent causes
of admission to a psychogeriatric ward for patients with
dementia were agitation, effective (or risk of ) harm, and
sheltering. Some causes were associated with specific
profiles: delusional ideas and hallucinations were more
frequent among patients in the BPSD-psychotic profile
(χ2(3542) = 33.97, p < 0.000), and self-harm (whether a
risk or real) was more frequent among patients charac-
terized by the BPSD-affective profile (χ2(3542) = 9.36,
p = 0.025). These differences were also judged to be
clinically relevant.
The mean MMSE score also varied significantly across
the profiles, with a lower score in the BPSD-somatic
profile than in the BPSD-affective or BPSD-psychotic
profiles (F(3289) = 4.435, p = 0.005). The MMSE scores
of 46 % of patients who met the present study’s inclu-
sion criteria are missing; this was mainly due to the
difficulties of carrying out cognitive testing on acutely
ill psychiatric patients or those with advanced
Table 3 Distribution of the HoNOS65+ item (8) “Other mental and behavioral problems” responses among the four profiles
HoNOS-8 Total N = 542 BPSD-affective n = 233 BPSD-functional n = 95 BPSD-somatic n = 137 BPSD-psychotic n = 77
Total of item 8 rated 1 or more, n (%) 443 (81.7) 195 (83.7) 56 (58.9) 124 (90.5) 68 (88.3)
A) Phobias 2 (0.5) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.8)
B) Anxiety and panic 294 (66.4) 133 (68.2) 43 (76.8) 74 (59.7) 44 (64.7)
C) Obsessive-compulsive symptoms 2 (0.5) 0 (0.0) 0 (0.0) 2 (1.6) 0 (0.0)
D) Mental strain and tension 7 (1.6) 6 (3.1) 0 (0.0) 0 (0.0) 1 (1.5)
E) Dissociative or conversion problems 1 (0.2) 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0)
F) Somatoform problems 1 (0.2) 1 (0.5) 0 (0.0) 0 (0.0) 0 (0.0)
G) Eating – over/under 43 (9.7) 18 (9.2) 2 (3.6) 12 (9.7) 11 (16.2)
H) Sleep – hypersomnia/insomnia 64 (14.4) 25 (12.8) 6 (10.7) 25 (20.2) 8 (11.8)
I) Sexual problems 6 (1.4) 2 (1.0) 1 (1.8) 3 (2.4) 0 (0.0)
J) Other 23 (5.2) 9 (4.6) 4 (7.1) 8 (6.5) 2 (2.9)
Table 4 Causes of admission according to the four profiles
Reasons of admission BPSD-affective n (%) BPSD-functional n (%) BPSD-somatic n (%) BPSD-psychotic n (%) p-value
Agitation 72 31 34 28 0.313
(30.9 %) (32.6 %) (24.8 %) (36.4 %)
Harm (risk or effective) 67 23 45 29 0.228
(28.8 %) (24.4 %) (32.8 %) (37.7 %)
Sheltering 38 23 22 13 0.339
(16.3 %) (24.2 %) (16.1 %) (16.9 %)
Denial of care services 25 14 21 13 0.422
(10.7 %) (14.7 %) (15.3 %) (16.9 %)
Delusional ideas and hallucinations 32 7 5 23 <0.001*
(13.7 %) (7.4 %) (3.6 %) (29.9 %)
Care impossible at home 25 9 18 8 0.824
(10.7 %) (9.5 %) (13.1 %) (10.4 %)
Self-harm (risk or effective) 33 10 9 3 0.025*
(14.2 %) (10.5 %) (6.6 %) (3.9 %)
*p < 0.05 for χ2 tests
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dementia, or it was not considered clinically useful at
hospital admission. Thus 46.5, 47.6, 29, 25 % of poten-
tial data was missing from the BPSD-psychotic, BPSD-
somatic, BPSD-affective, and BPSD-functional profiles,
respectively, because of the impossibility to carry out
the MMSE evaluation.
The CIRS-G scores were also associated with particu-
lar profiles (F(3538) = 16.823, p < 0.000). Specifically, the
BPSD-somatic profile had a higher comorbidity score
than the BPSD-affective and BPSD-psychotic profiles,
and the BPSD-functional profile presented the lowest
comorbidity score.
Patients’ legal admission status (i.e. whether admission
was voluntary or not) was also associated with the profiles
(χ2(6542) = 19.38, p = 0.004). Non-voluntary hospital ad-
missions made up significant proportions of all the pro-
files: 80 % for BPSD-affective; 83 % for BPSD-functional;
94 % for BPSD-somatic; and 93 % for BPSD-psychotic.
Finally, a Kruskal-Wallis test showed that the length
of stay in acute care facilities varied across profiles
(p = 0.034). Patients in the BPSD-affective profile had
the shortest stays, with a median stay estimated at
34 days. The median stays for the other profiles var-
ied between 41 and 45 days.
Discussion
This study describes the development of four stable, valid,
and reliable cluster profiles useful for distinguishing pro-
files of psychogeriatric patients hospitalized due to BPSD.
Our clustering solution allows to identify key issues
for clinical management by combining agitation, psycho-
logical features (depression and psychotic symptoms),
somatic disorders, and functional level. The identified
profiles illustrate the complexity of the possible clinical
situations presented by hospitalized psychogeriatric pa-
tients with cognitive impairment. Due to the specificity
of these patients’ needs, the types of care and services
they require should consider their complex multifactor-
ial etiologies (e.g., [56]). It is important to note that the
sample included in this cluster analysis is limited to
patients hospitalized for BPSD as cluster analyses are
sensitive to the characteristics of the studied population
(34, 35). As our objective is to adapt care to the needs of
the patients hospitalized in psychogeriatrics with BPSD,
patients that differ from our population of interest
should not be included in the analysis contrary to other
classifications which have previously been developed based
on samples including adult patients or various healthcare
settings (acute, long-term stay or forensic).
Table 5 Variables not included in classification development
BPSD-affective BPSD-functional BPSD-somatic BPSD-psychotic p-value
Gender 233 95 137 77 0.469
Men n (%) 99 (42.48 %) 42 (44.21 %) 60 (43.79 %) 26 (33.76 %)
Women n (%) 134 (57.51 %) 53 (55.78 %) 77 (56.20 %) 51 (66.23 %)
Age in years n 233 95 137 77 0.074
mean 80.98 80.84 82.94 80.21
(95 % CI) (79.86–82.11) (79.18–82.49) (81.58–84.29) (78.16–82.25)
MMSE score n 134 65 60 34 0.005*
mean 18.49 17.06 15.03 18.12
(95 % CI) (17.42–19.55) (15.60–18.53) (13.34–16.73) (15.90–20.34)
CIRS-G score n 233 95 137 77 <0.001*
mean 18.72 16.53 22.14 20.36
(95 % CI) (17.92–19.51) (15.31–17.74) (21.05–23.23) (18.84–21.88)
Legal admission status n total 233 95 137 77 0.004*
voluntary admission n (%) 42 (18.02 %) 15 (15.78 %) 6 (4.37 %) 5 (6.49 %)
non-voluntary admission n (%) 188 (80.68 %) 79 (83.15 %) 129 (94.16 %) 72 (93.50 %)
Other n (%) 3 (1.3 %) 1 (1.1 %) 2 (1.5 %) 0 (0 %)
Length of stay, acute Days n 233 95 137 77 0.034*
median 34 41 43 45
(IQR) (37) (40) (32) (40)
Length of stay, total Days n 233 95 137 77 0.070
mean 55.47 72.18 58.61 62.16
(95 % CI) (48.48–62.46) (59.18–85.18) (51.05–66.17) (49.24–75.07)
*p < 0.05 for ANOVA (means) and Kruskall-Wallis tests (medians)
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The identified psychogeriatric profiles differed in terms
of clinical levels of complexity and significantly explained
variations in different clinical variables that have not been
used for their development but these results can seem ob-
vious : psychotic manifestations are a more frequent cause
of admission in the BPSD-psychotic profile or contribute to
a higher comorbidity score in the BPSD-somatic profile.
These results are limited by the fact that the study was
based on secondary data which constitutes its main limita-
tion. Indeed, only routinely collected clinical data were ac-
cessible whereas a systematic evaluation including patients’
functional level, BPSD frequency and severity at admission
would allow the identification of variables that can vary
between profiles. Likewise, only few of the considered
causes of admission were significantly different across the
four profiles. However, the variables included in the devel-
opment of the profiles took in account only patient-
centered variables which would not be affected by external
factors. The reasons that lead to hospitalization of the
patient with dementia and BSPD certainly include not only
clinical issues specific to the patient but also external fac-
tors, such as issues associated with living conditions or the
caregiver’s health. As an example, a similar clinical situ-
ation can be managed at home for some BPSD patients
but not for others, explaining why the reason of admission
is not always associated with the profiles but more with
external variables such as the availability of caregivers.
Thus, it would be important for future research to examine
the interactions between patient profiles, the living condi-
tions and caregiver characteristics.
Two recent studies exploring our profiles shed light
on the potential clinical perspectives. We explored the
clinical course of these profile during hospitalization
[57] and showed relative stability or improvement of
patients: those who present BPSD-functional and
BPSD-affective profiles remained in the same profile at
discharge and those who present BPSD-somatic and
BPSD-psychotic profiles showed clinical improvement
during their hospitalization, transitioning to BPSD-
functional or BPSD-affective profiles. Overall, the level
of patients’ functional abilities remained the same dur-
ing hospitalization as opposed to the decrease in
BPSD. With regards to living arrangements after dis-
charge, despite clinical improvement in most of the
patients, the majority of them were institutionalized
independently of the profile. Nevertheless, profiles
were also associated with a specific living arrangement
at discharge. Patients with a BPSD-affective profile
had a higher probability of going back home and
patients with a BPSD-somatic or BPSD-psychotic profile
had a much higher probability of being hospitalized in
acute wards or of dying compared to the BPSD-functional
profile. This is evidence of a somatic decompensation.
Patients with BPSD-somatic or BPSD-psychotic profiles
displayed the most critical clinical health status of psycho-
geriatric inpatients compared to others with BPSD.
The aim of the second study was to describe the ob-
servations and nursing interventions that were recorded
in the charts of the four profiles at admission. The study
also aimed to identify the interventions considered most
relevant for each profile through a structured exercise of
consensus between experts. It helped to identify four
types of interventions that are common to all profiles, and
between two to five types of interventions specifically as-
sociated to each profile. The comparison of the interven-
tions reported in the charts and those recommended by
the experts offered potential perspective to improve nurs-
ing care in acute psychogeriatric wards [58].
This study has some limitations. As discussed above,
due to the retrospective nature of this study, only rou-
tinely collected clinical data were accessible. With regard
to external validity, it has not yet been possible to valid-
ate our findings on a different population sample. This
raises the question of whether this profile solution could
be applicable in other health care contexts. Indeed, a
profile solution naturally depends to a great extent on
the characteristics of the subjects classified and the
organization of the healthcare system in place.
Thanks to the validity and reliability of our profiles in
the present study, the future perspectives for research
are multiple. Firstly, our solution can be used to develop
a classification system. Indeed, based on the similarity
(or distance) measure that has been used to develop the
clustering solution, a new patient can be classified into a
profile. Based on the values of the HoNOS65+ items of
the new patient, the distance from each centroid of each
group can be calculated, and the new patient can be
assigned to the profile from which their distance to the
centroid is minimal. This calculation algorithm could be
easily developed and implemented in current electronic
patient records. Moreover, it would be interesting to
continue collecting clinical data associated with the
profiles selected in order to more accurately determine
their clinical course during hospitalization. Secondly, a
systematic evaluation of patients’ functional level, the
quality of their formal and informal networks, and their
cognitive level at the different stages of hospitalization
would be advantageous. Thirdly, with a more refined
understanding of each profile, it might be possible to
develop and test care-plan guidelines adapted to each
one of them. Classifying patient according to clinical
profiles could contribute to more easily identify the
major issues in order to promptly plan tailored actions.
According to the definition of the European Pathway As-
sociation, integrated care pathways are a “complex inter-
vention to support decision making and organization of
care expected for a group of well-defined patients during a
determined period” [59]. Thus, integrated care pathways
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can be addressed to patient groups that can be defined by
patient profiles sharing similar characteristics. Because of
their attributes, integrated care pathways are renowned for
being able to better focus care on patient needs [60–62],
reduce the number of hospital readmissions and lengths of
stay, whilst improving the quality, safety, and efficiency of
care [61, 63–66]. This issue is important because integrated
care pathways are mainly restricted to monitoring patients
with an accurate medical diagnosis (such as diabetes or re-
spiratory diseases) [61, 63, 67, 68]. There are currently no
comprehensive care plans for managing patients with
BPSD hospitalized in psychogeriatric wards.
Conclusions
Aged patients with dementia are a heterogeneous popula-
tion. The present study offers a four-profile solution which
can serve to implement a new classification system for
aged patients with BPSD according to their clinical char-
acteristics when they are hospitalized in psychogeriatric
units. These profiles have been validated statistically and
clinically, and they are based on reliable clinical measure-
ments systematically collected in daily practice. Because
these profiles are associated with several clinical and psy-
chosocial characteristics, they are likely to allow the devel-
opment of patient-centered care plans.
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